Homepage
Education
News
Solriamfetol improved objective and subjective measures of cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS), according to a poster presentation at Psych Congress.
Sleep disorders are a common experience for individuals with psychosis, and understanding how they manifest may help clinicians develop tailored treatment.
Sleep issues were common in adults with major depressive episodes who went on to develop other psychiatric disorders, according to study results published online in The Journal of Clinical Psychiatry.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
Videos
Posters
SHARP evaluated the effects of solriamfetol on cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA)and excessive daytime sleepiness (EDS).